🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/04/2008 | 36,93 | 38,46 | 36,90 | 38,14 | +3,50% | 4,24% | 17.999.819 |
| 23/04/2008 | 36,99 | 37,10 | 36,26 | 36,85 | +0,29% | 2,27% | 18.825.329 |
| 22/04/2008 | 37,81 | 37,95 | 36,60 | 36,75 | -2,83% | 3,56% | 20.458.427 |
| 21/04/2008 | 38,78 | 38,90 | 36,97 | 37,81 | -0,33% | 5,00% | 23.383.395 |
| 18/04/2008 | 37,60 | 38,29 | 37,21 | 37,94 | +1,38% | 2,87% | 27.103.271 |
| 17/04/2008 | 38,27 | 38,60 | 37,29 | 37,42 | -2,70% | 3,42% | 24.721.062 |
| 16/04/2008 | 39,59 | 39,59 | 37,90 | 38,46 | -2,21% | 4,27% | 27.563.658 |
| 15/04/2008 | 39,96 | 40,31 | 38,89 | 39,33 | -0,43% | 3,53% | 19.685.527 |
| 14/04/2008 | 39,25 | 39,61 | 38,92 | 39,50 | +0,63% | 1,75% | 14.222.932 |
| 11/04/2008 | 39,60 | 39,93 | 39,12 | 39,26 | -1,37% | 2,05% | 14.684.471 |
| 10/04/2008 | 39,73 | 40,26 | 39,48 | 39,80 | +1,88% | 1,95% | 17.382.757 |
| 09/04/2008 | 39,06 | 39,23 | 38,53 | 39,06 | +0,10% | 1,78% | 11.941.750 |
| 08/04/2008 | 38,65 | 39,53 | 38,47 | 39,03 | +0,29% | 2,74% | 18.868.506 |
| 07/04/2008 | 38,71 | 39,69 | 38,61 | 38,91 | +1,95% | 2,81% | 24.007.479 |
| 04/04/2008 | 36,56 | 38,24 | 36,34 | 38,17 | +4,28% | 5,22% | 31.954.149 |
| 03/04/2008 | 35,44 | 36,70 | 35,31 | 36,60 | +3,40% | 3,93% | 54.516.646 |
| 02/04/2008 | 36,67 | 36,83 | 35,27 | 35,40 | -3,18% | 4,27% | 41.527.734 |
| 01/04/2008 | 36,63 | 37,08 | 36,31 | 36,56 | +0,98% | 2,11% | 43.345.804 |
| 31/03/2008 | 36,98 | 37,69 | 35,13 | 36,21 | -14,74% | 6,92% | 85.731.011 |
| 28/03/2008 | 42,71 | 43,64 | 42,35 | 42,47 | -0,60% | 3,02% | 11.887.778 |
| 27/03/2008 | 42,67 | 43,29 | 42,18 | 42,73 | +0,18% | 2,62% | 20.682.804 |
| 26/03/2008 | 42,49 | 42,98 | 42,18 | 42,65 | +0,07% | 1,89% | 21.383.497 |
| 25/03/2008 | 42,32 | 42,94 | 42,22 | 42,62 | +0,95% | 1,69% | 14.061.121 |
| 24/03/2008 | 41,62 | 42,73 | 41,28 | 42,22 | +2,05% | 3,48% | 18.329.520 |
| 20/03/2008 | 41,59 | 41,59 | 40,08 | 41,37 | +0,86% | 3,65% | 17.209.522 |
| 19/03/2008 | 41,33 | 41,98 | 40,94 | 41,02 | -0,46% | 2,52% | 16.114.782 |
| 18/03/2008 | 40,40 | 41,22 | 39,85 | 41,21 | +3,20% | 3,40% | 15.363.366 |
| 17/03/2008 | 38,65 | 40,13 | 38,28 | 39,93 | +2,15% | 4,79% | 15.763.073 |
| 14/03/2008 | 40,38 | 41,00 | 38,73 | 39,09 | -2,29% | 5,62% | 17.797.450 |
| 13/03/2008 | 40,36 | 40,75 | 39,64 | 40,01 | -1,23% | 2,77% | 21.246.418 |